Trials (Jun 2020)
Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
- Bastiaan Maes,
- Cedric Bosteels,
- Elisabeth De Leeuw,
- Jozefien Declercq,
- Karel Van Damme,
- Anja Delporte,
- Bénédicte Demeyere,
- Stéfanie Vermeersch,
- Marnik Vuylsteke,
- Joren Willaert,
- Laura Bollé,
- Yuri Vanbiervliet,
- Jana Decuypere,
- Frederick Libeer,
- Stefaan Vandecasteele,
- Isabelle Peene,
- Bart N. Lambrecht
Affiliations
- Bastiaan Maes
- VIB-UGent Inflammatie-researchcentrum
- Cedric Bosteels
- VIB-UGent Inflammatie-researchcentrum
- Elisabeth De Leeuw
- VIB-UGent Inflammatie-researchcentrum
- Jozefien Declercq
- VIB-UGent Inflammatie-researchcentrum
- Karel Van Damme
- VIB-UGent Inflammatie-researchcentrum
- Anja Delporte
- VIB-UGent Inflammatie-researchcentrum
- Bénédicte Demeyere
- VIB-UGent Inflammatie-researchcentrum
- Stéfanie Vermeersch
- VIB-UGent Inflammatie-researchcentrum
- Marnik Vuylsteke
- VIB-UGent Inflammatie-researchcentrum
- Joren Willaert
- VIB-UGent Inflammatie-researchcentrum
- Laura Bollé
- VIB-UGent Inflammatie-researchcentrum
- Yuri Vanbiervliet
- VIB-UGent Inflammatie-researchcentrum
- Jana Decuypere
- VIB-UGent Inflammatie-researchcentrum
- Frederick Libeer
- VIB-UGent Inflammatie-researchcentrum
- Stefaan Vandecasteele
- VIB-UGent Inflammatie-researchcentrum
- Isabelle Peene
- VIB-UGent Inflammatie-researchcentrum
- Bart N. Lambrecht
- VIB-UGent Inflammatie-researchcentrum
- DOI
- https://doi.org/10.1186/s13063-020-04519-4
- Journal volume & issue
-
Vol. 21,
no. 1
pp. 1 – 1
Abstract
An amendment to this paper has been published and can be accessed via the original article.
